Celldex Therapeutics (CLDX) Q4 2021 Earnings

9NovConfirmed
Q4 2020
Q2 2021
Q3 2021
Q4 2021
-0.45
-0.41
-0.38
-0.34

Details

Expected EPS
-0.35
Actual EPS
-0.45
Surprise EPS
-0.1
Surprise Percent
+28.57%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.45 per share for Q4 2021.

0 Comments

Share your thoughts